464 related articles for article (PubMed ID: 28252637)
1. Hepatitis C virus infection.
Manns MP; Buti M; Gane E; Pawlotsky JM; Razavi H; Terrault N; Younossi Z
Nat Rev Dis Primers; 2017 Mar; 3():17006. PubMed ID: 28252637
[TBL] [Abstract][Full Text] [Related]
2. [RESISTANCE OF HCV TO NEW DIRECT ACTING ANTIVIRALS].
Gozlan Y; Mendelson E; Ben-Ari Z; Mor O
Harefuah; 2015 Nov; 154(11):684-7, 743. PubMed ID: 26821497
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis, diagnosis and management of hepatitis C.
Boyer N; Marcellin P
J Hepatol; 2000; 32(1 Suppl):98-112. PubMed ID: 10728798
[TBL] [Abstract][Full Text] [Related]
4. Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.
De Monte A; Courjon J; Anty R; Cua E; Naqvi A; Mondain V; Cottalorda J; Ollier L; Giordanengo V
J Clin Virol; 2016 May; 78():27-30. PubMed ID: 26967675
[TBL] [Abstract][Full Text] [Related]
5. [Progress in Examination and Treatment of Hepatitis C Virus].
Suda G; Sakamoto N
Rinsho Byori; 2015 Jun; 63(6):762-7. PubMed ID: 26548242
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus.
Pietschmann T; Brown RJP
Trends Microbiol; 2019 Apr; 27(4):379-380. PubMed ID: 30709707
[TBL] [Abstract][Full Text] [Related]
7. Direct-acting Antiviral Agents Resistance-associated Polymorphisms in Chinese Treatment-naïve Patients Infected with Genotype 1b Hepatitis C Virus.
Wang Y; Rao HY; Xie XW; Wei L
Chin Med J (Engl); 2015 Oct; 128(19):2625-31. PubMed ID: 26415801
[TBL] [Abstract][Full Text] [Related]
8. Resistance to direct antiviral agents in patients with hepatitis C virus infection.
Sarrazin C; Zeuzem S
Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612
[TBL] [Abstract][Full Text] [Related]
9. Promising Anti-Hepatitis C Virus Compounds from Natural Resources.
Wahyuni TS; Utsubo CA; Hotta H
Nat Prod Commun; 2016 Aug; 11(8):1193-1200. PubMed ID: 30725589
[TBL] [Abstract][Full Text] [Related]
10. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
Chehadeh W; Al-Nakib W
J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
[TBL] [Abstract][Full Text] [Related]
11. Consensus guidelines for the management of hepatitis C infection.
Consensus Guidelines Committee for the Management of Hepatitis C Infection
Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring NS3 resistance-associated variants in hepatitis C virus genotype 1: Their relevance for developing countries.
Echeverría N; Betancour G; Gámbaro F; Hernández N; López P; Chiodi D; Sánchez A; Boschi S; Fajardo A; Sóñora M; Moratorio G; Cristina J; Moreno P
Virus Res; 2016 Sep; 223():140-6. PubMed ID: 27449600
[TBL] [Abstract][Full Text] [Related]
13. Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease.
Ogata F; Kobayashi M; Akuta N; Osawa M; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
Oncology; 2017; 93(2):92-98. PubMed ID: 28448999
[TBL] [Abstract][Full Text] [Related]
14. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
Pol S; Corouge M; Mallet V; Sogni P
Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C: epidemiology, diagnosis, natural history and therapy.
Pol S; Vallet-Pichard A; Corouge M; Mallet VO
Contrib Nephrol; 2012; 176():1-9. PubMed ID: 22310776
[TBL] [Abstract][Full Text] [Related]
16. New direct-acting antivirals' combination for the treatment of chronic hepatitis C.
Asselah T; Marcellin P
Liver Int; 2011 Jan; 31 Suppl 1():68-77. PubMed ID: 21205141
[TBL] [Abstract][Full Text] [Related]
17. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
18. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets.
Dwivedi M; Dwivedi A; Mukherjee D
Curr Drug Targets; 2023; 24(14):1127-1138. PubMed ID: 37907492
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis C].
Moradpour D; Blum HE
Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
[TBL] [Abstract][Full Text] [Related]
20. Genotype 3 Infection: The Last Stand of Hepatitis C Virus.
Chan A; Patel K; Naggie S
Drugs; 2017 Feb; 77(2):131-144. PubMed ID: 28074358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]